September 24, 2023
BeneCard PBF is committed to providing innovative clinical solutions, valuable trend management
strategies, and the highest quality of service. We regularly conduct a review of our formulary
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
International Medical Insurance
September 24, 2023
The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or
marketing unapproved ophthalmic drug products in violation of federal law
September 24, 2023
Three poly (ADP-ribose) polymerase inhibitor (PARPi) combination regimens have received FDA approval in
2023 for the first-line treatment of metastatic castration-resistant prostate cancer
September 15, 2023
September 15, 2023 - GSK plc. announced that the U.S. Food and Drug Administration has
approved Ojjaara (momelotinib) for the treatment of intermediate
September 11, 2023
September 11, 2023 - Novartis is conducting a voluntary nationwide recall at the consumer level
September 11, 2023
September 11, 2023 - Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug
Administration (FDA) approved the supplemental Biologics License
September 11, 2023
Sept. 11, 2023 - BioLineRx Ltd., a commercial stage biopharmaceutical company focused on certain cancers
and rare diseases, has announced
August 24, 2023
August 24, 2023 - The U.S. Food and Drug Administration has approved Tyruko (natalizumab-sztn), the first
biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms